@article{ref1,
title="Pharmacotherapy of suicidal behavior in bipolar disorder",
journal="Archives of suicide research",
year="2005",
author="Oquendo, Maria A. and Chaudhury, Sadia R. and Mann, J. John",
volume="9",
number="3",
pages="237-250",
abstract="Patients with Bipolar Disorder (BD) are at particularly high risk for both attempted and completed suicides. The period of highest risk for completed suicide is during the 2 years following discharge from a hospitalization. To date, pharmacological studies of suicidal behavior in BD have been quite limited. While strong evidence has been found regarding the anti-suicidal effects of lithium, evidence for such properties in other commonly prescribed medications for BD, including anticonvulsants, SSRIs and anti-psychotics, has been largely unexplored. Considering the high risk of suicidal acts in patients with BD, further research on the pharmacotherapy of suicidal behavior is crucial.<p /> <p>Language: en</p>",
language="en",
issn="1381-1118",
doi="10.1080/13811110590929424",
url="http://dx.doi.org/10.1080/13811110590929424"
}